Sunshine Joel, Green Jordan J, Mahon Kerry P, Yang Fan, Eltoukhy Ahmed A, Nguyen David N, Langer Robert, Anderson Daniel G
Department of Biomedical Engineering The Johns Hopkins University School of Medicine Baltimore, MD 21205 (USA).
David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology Cambridge, MA 02139 (USA).
Adv Mater. 2009 Dec 28;21(48):4947-4951. doi: 10.1002/adma.200901718. Epub 2009 Aug 15.
End-modified polymers are promising for the nonviral delivery of genes to cancer cells, immune cells, and human stem cells and point to polymer end-groups as regulators for cell-type specificity. A library of polymers has been synthesized and, although some polymers are strong transfection agents overall, for each cell type, a particular polymer is most effective.
Biomacromolecules. 2011-9-9
Acc Chem Res. 2011-8-26
Biomaterials. 2024-12
Proc Natl Acad Sci U S A. 2023-6-27
Mol Ther Nucleic Acids. 2023-4-23
Pharmaceutics. 2023-4-17
Adv Sci (Weinh). 2023-2
APL Bioeng. 2021-8-26
Mol Aspects Med. 2022-2
Nano Lett. 2008-10
Bioconjug Chem. 2006
Nat Mater. 2006-6
Pharmacol Rev. 2006-3
Nat Rev Drug Discov. 2005-7